Health
C.D.C. Cuts Threaten to Set Back the Nation’s Health, Critics Say

The extensive layoffs of federal health workers that began on Tuesday will greatly curtail the scope and influence of the Centers for Disease Control and Prevention, the world’s premier public health agency, an outcome long sought by conservatives critical of its handling of the Covid-19 pandemic.
The reorganization of the Department of Health and Human Services shrinks the C.D.C. by 2,400 employees, or roughly 18 percent of its work force, and strips away some of its core functions.
Some Democrats in Congress described the reorganization throughout H.H.S. as flatly illegal.
“You cannot decimate and restructure H.H.S. without Congress,” said Senator Patty Murray, Democrat of Washington, and a member of the Senate health committee.
“This is not only unlawful but seriously harmful — they are putting Americans’ health and well-being on the line,” she added.
Ms. Murray noted that the Trump administration had not detailed which units are being cut at the C.D.C. and other health agencies. Robert F. Kennedy Jr., the health secretary, said last week the layoffs would affect primarily administrative functions.
But according to information gathered by The New York Times from dozens of workers, the reductions were more broadly targeted. Scientists focused on environmental health and asthma, injuries, lead poisoning, smoking and climate change were dismissed.
Researchers studying blood disorders, violence prevention and access to vaccines were let go. The agency’s center on H.I.V. and sexually transmitted diseases was among the hardest hit, losing about 27 percent of its staff.
The National Institute for Occupational Safety and Health, which makes recommendations on how to keep workers safe, was all but dissolved.
What remains is a hobbled C.D.C., with a smaller global footprint, devoting fewer resources to environmental health, occupational health and disease prevention, public health experts said.
Instead, the agency will be trained more narrowly on domestic disease outbreaks. Communications will be centralized at H.H.S. in Washington.
The department intends “to ensure a more coordinated and effective response to public health challenges, ultimately benefiting the American taxpayer,” said Emily Hilliard, deputy press secretary at the department.
“C.D.C. scientists have conducted numerous interviews on a variety of topics and will continue to do so,” she added.
Critics predicted the move would prevent scientists from speaking frankly about public health.
“American taxpayers provide the resources for C.D.C.’s specialists and have the right to hear directly from them without interference by politicians,” said Dr. Thomas R. Frieden, who led the agency from 2009 to 2017.
The sweeping reductions arrive as the nation confronts an outbreak of measles in Texas and elsewhere, a spreading bird flu epidemic on poultry and dairy farms, and a raft of new questions about public health measures like water fluoridation and school vaccine requirements.
“What we seem to be seeing is a dismantling rather than a restructuring” of the public health system, said Dr. Richard Besser, chief executive of the Robert Wood Johnson Foundation and a former acting director of the C.D.C.
On Capitol Hill, the Senate health committee, which recommended confirmation of Mr. Kennedy as secretary, scheduled a hearing on the reorganization of H.H.S., citing the possible impacts on public health.
Mr. Kennedy has described the reorganization as an effort to clean up waste and bureaucracy while promising that federal health agencies would do more to improve the health of Americans.
“We’re going to eliminate an entire alphabet soup of departments and agencies while preserving their core functions by merging them into a new organization called the Administration for a Healthy America,” the secretary said in a videotaped message announcing the layoffs.
The department did not respond to requests for more detailed information.
Society’s most vulnerable — the poor, Black, Latino and Native American people, rural Americans with less access to health care, the disabled and those at highest risk for illness — are likely to be hit hardest, experts said.
“These communities rely on public health to a larger extent than wealthy communities do,” Dr. Besser said.
For decades, public health and medical research drew support across the political spectrum.
But the C.D.C. has been in the political cross hairs since the first Trump administration, when the White House muzzled the agency’s communications, meddled with its publications and blamed its scientists for bungling the pandemic response.
In recent years, lawmakers have harshly criticized the agency’s advice on masks, lockdowns, social distancing, school closures and various other attempts to contain the pandemic, calling them economically and socially disastrous.
Project 2025, the conservative blueprint for reshaping the federal government, described the C.D.C. as “perhaps the most incompetent and arrogant” federal agency, and called on Congress to curb its powers.
Through staffing cuts, the administration reduced critical divisions of the National Center for Injury Prevention and Control, and employees studying how to prevent gun violence, child abuse and elder abuse were fired.
Injuries are the leading cause of death among Americans under 45. About 47,000 Americans are killed by firearms each year, more than half of them suicides.
But gun violence is a politically fraught topic. Pressure from the National Rifle Association and conservative politicians led to a ban on using federal funds to study gun violence for almost 25 years. Funding was restored in 2019.
The injury center studied ways to improve gun safety and promoted the use of gun locks, particularly in homes where children live.
“People think of gun violence as a question for law enforcement, but the public health approach has made a big difference,” said Dr. Mark Rosenberg, a former center director.
Most of the C.D.C.’s Division of Reproductive Health, which studies maternal health, was also shuttered. Whether some or all of its portfolio will be assumed by the new organization created by Mr. Kennedy was not clear.
Pregnant women and newborns die in the United States at a far higher rate than in other industrialized nations.
In recent years, the C.D.C. focused on stark racial health disparities that put Black American women at nearly three times the risk of dying of pregnancy complications than white women.
But the Trump administration has been defunding studies of health disparities in racial, ethnic and gender minorities, saying they do not align with the president’s executive orders ending diversity, equity and inclusion initiatives.
Mr. Kennedy said last week that the National Institute for Occupational Safety and Health, which makes recommendations for preventing work-related injuries and illnesses, would be absorbed into the health department.
But on Tuesday, most of its divisions were eliminated, among them offices dedicated to protecting workers in various industries, including mine inspectors.
Even one of the agency’s most essential functions, infectious disease research, was affected.
The Trump administration had been weighing moving the H.I.V. prevention division to a different agency within the health department.
But on Tuesday, teams leading H.I.V. surveillance and research within that division were laid off. It was unclear whether some of those functions would be recreated elsewhere. (A team in the global health center working on preventing mother-to-child transmission of H.I.V. was also cut.)
Until now, the C.D.C. provided funds to states and territories for responding to and preventing H.I.V. outbreaks. Roughly one in four new diagnoses of H.I.V. is made with agency funds.
Some H.I.V. experts warned that the move could lead to a rise in H.I.V. infections among Americans.
“H.I.V. prevention is a lot more than just giving out condoms,” said Dr. John Brooks, who served as chief medical officer for the division of H.I.V. prevention until last year. “It saves lives, averts illness and produces enormous cost savings.”
Broadly, the reorganization aligns with Mr. Kennedy’s preferred emphasis on research into chronic diseases; federal research has been far too focused on infectious diseases, he has said.
But the line between them is not always clear, said Dr. Anne Schuchat, former principal deputy director of the C.D.C. Research that seems disconnected from outbreak response may also be a key for fighting pathogens.
“For Zika, we needed experts in birth defects, entomology and vector control, virologists and environmental health experts,” she said. “Emerging threats don’t respect borders of C.D.C. organizational units.”
The reorganization risks choking the talent pipeline for public health, said Ursula Bauer, former director of the agency’s National Center for Chronic Disease Prevention and Health Promotion.
“Once you decimate an agency like C.D.C., which is full of high-caliber highly trained individuals, building back is going to be incredibly difficult,” she said.
“It will take two to three times as long to undo the damage as it took to inflict it.”
The cuts also will take a toll on the agency’s ability to gather and analyze data, which are keys to identifying trends and developing interventions, Dr. Phil Huang, director of Dallas County Health and Human Services, said at a news briefing.
“You take away those systems, and it takes away the ability to see the impact of all these cuts,” he added.

Health
Experts: How to Prevent Muscle Loss on Ozempic | Woman's World

Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
Health
Alzheimer's disease could be prevented by antiviral drug already on market

An existing drug for HIV could double as a preventative therapy for Alzheimer’s disease, according to researchers.
NRTIs (nucleoside reverse transcriptase inhibitors) are antivirals that are approved to treat HIV infection, but scientists from UVA Health at the University of Virginia found that patients taking them were less likely to develop the common form of dementia.
There was a roughly 10% annual reduction in the risk of developing Alzheimer’s disease in people taking NRTIs for every year of use of these drugs, according to lead study author Dr. Jayakrishna Ambati, M.D., professor of ophthalmology at UVA, who spoke to Fox News Digital about the finding.
ALZHEIMER’S BRAIN TREATMENT SHOWS PROMISING RESULTS IN NEW STUDY
After coming across another mechanism that could potentially prevent Alzheimer’s, the researchers analyzed 24 years of health insurance data, including 270,000 patients.
The Alzheimer’s risk reduction among patients taking NRTIs was “significant and substantial,” the researchers wrote in the findings, which were published in the journal Alzheimer’s & Dementia.
An existing drug for HIV could double as a preventative therapy for Alzheimer’s disease, according to researchers. (iStock)
Now, the UVA team is calling for clinical trials of NRTIs to gauge their use for treating Alzheimer’s.
Approximately 10 million people worldwide are diagnosed with the common dementia each year.
ALZHEIMER’S RATES HAVE REACHED STAGGERING NUMBER AS EXPERTS CALL FOR CHANGE
“This level of protection could translate into 60,000 fewer cases of Alzheimer’s disease every year in our country, and up to one million fewer cases every year around the world,” Ambati told Fox News Digital.
In addition to keeping the HIV virus from replicating, NRTIs also prevent the activation of inflammasomes, proteins that are involved in the development of Alzheimer’s.

“This level of protection could translate into 60,000 fewer cases of Alzheimer’s disease every year in our country, and up to one million fewer cases every year around the world,” the lead study author told Fox News Digital. (iStock)
“We had previously shown that NRTIs blocked the inflammasome, so it wasn’t altogether surprising that people taking NRTIs might be protecting against this disease,” Ambati noted.
“However, the degree of protection against Alzheimer’s was quite surprising.”
“It is very possible that this drug may be useful in Alzheimer’s prevention.”
Dr. Marc Siegel, clinical professor of medicine at NYU Langone Health and Fox News senior medical analyst, was not involved in the study but commented on the findings.
“Inflammasomes are intracellular protein complexes that trigger the release of inflammatory cytokines,” he told Fox News Digital. “HIV uses these inflammasomes to fight the immune system.”

Repurposing existing drugs can offer a “promising pathway,” according to an expert from the Alzheimer’s Association. (iStock)
“These chemicals are likely responsible for making Alzheimer’s worse, or for accelerating the process of cognitive decline based on neuro-inflammation.”
Rebecca Edelmeyer, Ph.D., vice president of Scientific Engagement at the Alzheimer’s Association in Chicago, also reviewed the study’s findings, which she called “interesting.”
‘I’M A NEUROLOGIST — HERE’S WHY DEMENTIA IS RISING AND HOW TO REDUCE YOUR RISK’
“Further research and specifically designed clinical trials are needed to fully understand the potential future use of NRTIs to reduce the risk of Alzheimer’s, but the study highlights the potential role drug repurposing can play in advancing new Alzheimer’s treatments,” she told Fox News Digital.
Repurposing existing drugs can offer a “promising pathway,” according to Edelmayer. As existing drugs’ safety and side effects are often already known, the studies can be quicker and less expensive than with new treatments, she added.
Potential limitations and next steps
The research team acknowledged some limitations of the study.
“Like all retrospective health insurance database studies, the findings of our study are an association between this class of drugs and the development of Alzheimer’s disease,” Ambati told Fox News Digital.
“They don’t necessarily provide a cause and effect — however, the fact that we found this link in multiple databases increases confidence in this result.”
Siegel agreed that the new study is observational, but noted that it takes place over many years.
“It also shows that only this particular HIV drug — inflammasome — dramatically decreases the risk of Alzheimer’s, not the other HIV drugs, including protease inhibitors,” the doctor said.

Nearly seven million people in the U.S. are currently living with Alzheimer’s, and the number is expected to reach 13 million by 2050, according to the Alzheimer’s Association. (iStock)
“I think this is convincing preliminary evidence that warrants further study,” Siegel added. “It is very possible that this drug may be useful in Alzheimer’s prevention, given the increasing evidence implicating immune dysregulation and inflammation as causes of AD.”
Looking ahead, the researchers have developed a new drug called K9. Like NRTIs, the novel medication blocks inflammasomes, but is “safer and more effective,” according to Ambati.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“The fact that the new drug reversed memory loss and improved spatial learning in mice further increases confidence in our findings,” he told Fox News Digital.
The UVA team now plans to test K9 in clinical trials for Azheimer’s.

The study author cautioned that people should not take NRTIs for Alzheimer’s prevention unless they are in the context of a clinical trial. (iStock)
Ambati noted that people should not take NRTIs for Alzheimer’s prevention unless they are in the context of a clinical trial.
“If interested, they should be on the lookout for such trials for themselves or loved ones who may be affected,” he advised.
For more Health articles, visit www.foxnews.com/health
Nearly seven million people in the U.S. are currently living with Alzheimer’s, and the number is expected to reach 13 million by 2050, according to the Alzheimer’s Association.
The UVA study was funded in part by the UVA Strategic Investment Fund and the National Institutes of Health.
Health
Burn Belly Fat Fast With the New High-Protein Cabbage Soup Diet

Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
-
Austin, TX5 days ago
Best Austin Salads – 15 Food Places For Good Greens!
-
Technology1 week ago
Be careful what you read about an Elden Ring movie
-
Technology7 days ago
Netflix is removing Black Mirror: Bandersnatch
-
Culture1 week ago
Pulitzer Prizes 2025: A Guide to the Winning Books and Finalists
-
Education1 week ago
University of Michigan President, Santa Ono, Set to Lead University of Florida
-
World1 week ago
The Take: Can India and Pakistan avoid a fourth war over Kashmir?
-
News7 days ago
Reincarnated by A.I., Arizona Man Forgives His Killer at Sentencing
-
News1 week ago
Jefferson Griffin Concedes Defeat in N.C. Supreme Court Race